Amy Buckley

Amy Buckley is a Lecturer in Pharmacology at the University of New England (UNE), affiliated with the School of Health within the Faculty of Medicine and Health. She joined UNE in 2024 after extensive research and regulatory experience in pharmacology and oncology. She previously worked as a postdoctoral researcher at Queensland University of Technology and served as a Senior Evaluator at the Australian Pesticides and Veterinary Medicines Authority.

• BSc (Hons) in Pharmacology, University College Dublin
• PhD, Trinity College Dublin (2019), focusing on radiosensitization in oesophageal adenocarcinoma

Her research centers on overcoming treatment resistance in gastrointestinal cancers, particularly oesophageal adenocarcinoma. She investigates molecular mechanisms of radioresistance and chemoresistance, tumor metabolism, and the development of small molecule therapeutics to enhance treatment efficacy. Her work integrates pharmacological, metabolic, and proteomic approaches to understand tumor behavior under therapy.

The recent publications highlight a strong focus on radiosensitization, metabolic adaptation in tumors, and novel compounds like Pyrazinib and quininib. Her research spans translational oncology, drug development, and ex vivo tumor modeling, with recurring themes in angiogenesis, inflammatory signaling, and mitochondrial metabolism. These studies often involve patient-derived models and multi-omics analyses.

Scientific contributions include publications in high-impact journals such as Nature Reviews Gastroenterology & Hepatology, Cancer Letters, and Scientific Reports.

• Co-supervised MSc students in Translational Oncology at Trinity College Dublin
• No formal grants mentioned in the text, but her work implies collaborative, multidisciplinary research with clinical and translational applications

While no specific lab or research group is named at UNE, her background suggests active involvement in pharmacological and cancer research initiatives, likely contributing to UNE’s growing health sciences research profile.